IMSN encourages regulators and companies to improve medication safety at the global level
21 November 21 2016 - At the IMSN Global Regulatory Meeting: Designing Medication Safety at the Global Level held in Toronto, Canada on October 24, 2016, delegates from 17 member countries shared their views and concerns with invited regulators on factors that contribute to medication errors at a global level. Participants agreed on actions to be addressed immediately to protect patients from medication errors More...
International Position Statement on Safer Vaccine Packaging and Label Design
14 December 2015 - The International Medication Safety Network (IMSN) calls for greater worldwide attention to the problem of unsafe design of vaccine packaging and labelling. The IMSN position statement calls on healthcare professionals, pharmaceutical companies, technology vendors, professional organizations, and regulatory/standard-setting organizations to help improve vaccine safety and efficacy. More...
IMSN Alert – Risk of confusion between the names trastuzumab-emtansine and trastuzumab
8 May 2014 - International Medication Safety Network (IMSN) highly recommends that health care professionals be made aware of the risk of confusion between the names trastuzumab-emtansine and trastuzumab and that drug information systems and guidelines employ strategies to differentiate the names and warn against confusion as a proactive risk reduction strategy. More...
Unsafe Naming, Labeling and Packaging of Medicines: A Global Patient Safety Threat
14 October 2013 - After the Paris conference the IMSN issued a press release proposing that regulators and other stakeholders join IMSN at a summit in 2014 to address this global threat to patient safety. More...